Final Recommendation Statement: Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer

Final Update Summary: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication - US Preventive Services Task Force

The U.S. Preventive Services Task Force released today a final recommendation statement 
on aspirin use for the primary prevention of cardiovascular disease and colorectal cancer. 
Evidence shows that low-dose aspirin use is most beneficial for adults ages 50 to 59 years. 
Adults ages 60 to 69 years should decide with their primary care clinician if aspirin use for 
primary prevention is right for them. To view the recommendation and the evidence on 
which it is based, please go to http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/aspirin-to-prevent-cardiovascular-disease-and-cancer. A fact sheet 
that explains the final recommendation in plain language is also available on this page. 
The final recommendation statement can also be found in the April 12 online issue of
Annals of Internal Medicine.

Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication

Release Date: April 2016